Anemia

Anemia is an academic journal dedicated to anemia research, aiming to provide a platform for medical researchers, clinical doctors, and related professionals worldwide to exchange the latest research results, clinical practices, and theoretical discussions in the field of anemia. This magazine covers a wide range of topics related to anemia, including but not limited to the pathophysiology of anemia, diagnostic techniques, treatment strategies, epidemiological research, as well as complications and management associated with anemia. Anemia is a common blood disease characterized by a lower than normal level of red blood cells or hemoglobin content in the blood, leading to a decrease in oxygen transport capacity and potentially causing symptoms such as fatigue, pallor, palpitations, and difficulty breathing. The causes of anemia are diverse, including but not limited to blood loss, excessive destruction of red blood cells (hemolytic anemia), and insufficient red blood cell production (such as iron deficiency anemia, aplastic anemia).

The magazine ensures the scientific and innovative nature of its published articles through a rigorous peer review process, thereby promoting the development and progress of anemia research. This journal not only focuses on basic research, but also emphasizes clinical applications, providing readers with a comprehensive perspective from laboratory research to clinical practice. In addition, the magazine also pays special attention to the manifestations and treatment differences of anemia in different populations, such as children, pregnant women, and chronic disease patients.

《贫血》是一本专注于贫血研究的学术期刊，旨在为全球的医学研究人员、临床医生以及相关专业人士提供一个交流贫血领域最新研究成果、临床实践和理论探讨的平台。该杂志涵盖了贫血的广泛主题，包括但不限于贫血的病理生理学、诊断技术、治疗策略、流行病学研究以及与贫血相关的并发症和管理。贫血是一种常见的血液疾病，其特征是血液中的红细胞数量或血红蛋白含量低于正常水平，导致氧气运输能力下降，进而可能引发疲劳、苍白、心悸和呼吸困难等症状。贫血的成因多样，包括但不限于失血、红细胞破坏过度（溶血性贫血）、红细胞生成不足（如缺铁性贫血、再生障碍性贫血）等。

杂志通过严格的同行评审过程，确保发表的文章具有科学性和创新性，从而推动贫血研究的发展和进步。该期刊不仅关注基础研究，也重视临床应用，为读者提供从实验室研究到临床实践的全面视角。此外，该杂志还特别关注贫血在不同人群中的表现和治疗差异，如儿童、孕妇以及慢性疾病患者中的贫血问题。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映HEMATOLOGY领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为2.2，平均审稿速度为 18 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。